# Xylem Inc.: overview

XYL · NYSE · CIK 1524472 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xyl.md) · [Financials](/companies/xyl/financials.md) · [Filings](/companies/xyl/filings.md) · [Insiders](/companies/xyl/insiders.md)

Latest reported revenue: [$2.20bn](/filings/0001524472-26-000148.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 27, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001524472-26-000148).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,256 d](/filings/0001524472-26-000012.md) | [2,069](/filings/0001524472-26-000068.md) | [2,301](/filings/0001524472-26-000110.md) | [2,268](/filings/0001524472-26-000148.md) | [2,397 d](/filings/0001524472-26-000012.md) | [2,125](/filings/0001524472-26-000068.md) | [2,336](/filings/0001524472-26-000110.md) | [2,201](/filings/0001524472-26-000148.md) |
| Gross margin | % | [38.0% d](/filings/0001524472-26-000012.md) | [37.1%](/filings/0001524472-26-000068.md) | [38.8%](/filings/0001524472-26-000110.md) | [38.9%](/filings/0001524472-26-000148.md) | [38.9% d](/filings/0001524472-26-000012.md) | [37.8%](/filings/0001524472-26-000068.md) | [41.2%](/filings/0001524472-26-000110.md) | [41.2%](/filings/0001524472-26-000148.md) |
| Operating margin | % | [11.8% d](/filings/0001524472-26-000012.md) | [11.2%](/filings/0001524472-26-000068.md) | [13.3%](/filings/0001524472-26-000110.md) | [14.7%](/filings/0001524472-26-000148.md) | [14.7% d](/filings/0001524472-26-000012.md) | [11.5%](/filings/0001524472-26-000068.md) | [16.7%](/filings/0001524472-26-000110.md) | [17.5%](/filings/0001524472-26-000148.md) |
| Net margin | % | [14.5% d](/filings/0001524472-26-000012.md) | [8.2%](/filings/0001524472-26-000148.md) | [9.8%](/filings/0001524472-26-000148.md) | [10.0%](/filings/0001524472-26-000148.md) | [14.0% d](/filings/0001524472-26-000012.md) | [9.1%](/filings/0001524472-26-000148.md) | [11.3%](/filings/0001524472-26-000148.md) | [13.2%](/filings/0001524472-26-000148.md) |
| Diluted EPS | $ per share | not reported | [0.69](/filings/0001524472-26-000068.md) | [0.93](/filings/0001524472-26-000110.md) | [0.93](/filings/0001524472-26-000148.md) | not reported | [0.79](/filings/0001524472-26-000068.md) | [1.11](/filings/0001524472-26-000110.md) | [1.25](/filings/0001524472-26-000148.md) |
| Free cash flow | $m | [475 d](/filings/0001524472-26-000012.md) | [(38.0)](/filings/0001524472-26-000068.md) | [207 d](/filings/0001524472-26-000110.md) | [281 d](/filings/0001524472-26-000148.md) | [460 d](/filings/0001524472-26-000012.md) | [18.0](/filings/0001524472-26-000068.md) | [201 d](/filings/0001524472-26-000110.md) | [242 d](/filings/0001524472-26-000148.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,195](/filings/0001524472-24-000006.md) | [5,522](/filings/0001524472-25-000013.md) | [7,364](/filings/0001524472-26-000012.md) | [8,562](/filings/0001524472-26-000012.md) | [9,035](/filings/0001524472-26-000012.md) |
| Gross margin | % | [38.0%](/filings/0001524472-24-000006.md) | [37.7%](/filings/0001524472-25-000013.md) | [36.9%](/filings/0001524472-26-000012.md) | [37.5%](/filings/0001524472-26-000012.md) | [38.5%](/filings/0001524472-26-000012.md) |
| Operating margin | % | [11.3%](/filings/0001524472-24-000006.md) | [11.3%](/filings/0001524472-25-000013.md) | [8.9%](/filings/0001524472-26-000012.md) | [11.8%](/filings/0001524472-26-000012.md) | [13.5%](/filings/0001524472-26-000012.md) |
| Net margin | % | [8.2%](/filings/0001524472-24-000006.md) | [6.4%](/filings/0001524472-25-000013.md) | [8.3%](/filings/0001524472-26-000012.md) | [10.4%](/filings/0001524472-26-000012.md) | [10.6%](/filings/0001524472-26-000012.md) |
| Diluted EPS | $ per share | [2.35](/filings/0001524472-24-000006.md) | [1.96](/filings/0001524472-25-000013.md) | [2.79](/filings/0001524472-26-000012.md) | [3.65](/filings/0001524472-26-000012.md) | [3.92](/filings/0001524472-26-000012.md) |
| Free cash flow | $m | [330](/filings/0001524472-24-000006.md) | [388](/filings/0001524472-25-000013.md) | [566](/filings/0001524472-26-000012.md) | [942](/filings/0001524472-26-000012.md) | [910](/filings/0001524472-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xyl/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-29 | [Koch D Christian](/insiders/1190801.md) | Director | Purchase (P) | 11,000 | $89.60 | $985.6k | [Form 4](/filings/0001524472-26-000150.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.96bn | 25,037,896 |  | Reduced −615,921 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.84bn | 15,533,420 |  | Reduced −283,508 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.49bn | 12,618,888 |  | Reduced −152,341 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.35bn | 11,444,669 |  | Added +270,972 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $747.4m | 6,347,784 |  | Reduced −61,719 |
| [Amundi](/funds/1330387.md) | 2026-06-30 | $603.6m | 5,105,298 |  | Reduced −123,627 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $603.1m | 5,102,044 |  | Added +1,318,789 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $552.3m | 4,672,304 |  | Added +3,489,844 |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $544.4m | 4,605,175 |  | Reduced −158,066 |
| [Impax Asset Management Group plc](/funds/1749768.md) | 2026-06-30 | $528.3m | 4,468,984 |  | Reduced −116,564 |

## Recent filings

[All 1,313 filings](/companies/xyl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 12:26 ET | [10-Q](/filings/0001524472-26-000148.md) | Quarterly report, period 2026-09-30 | 0001524472-26-000148 |
| 2026-10-27 | 07:01 ET | [8-K](/filings/0001524472-26-000146.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001524472-26-000146 |
| 2026-09-29 | 16:21 ET | [8-K](/filings/0001524472-26-000134.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001524472-26-000134 |
| 2026-09-09 | 19:57 ET | [8-K](/filings/0001524472-26-000132.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001524472-26-000132 |
| 2026-08-18 | 09:03 ET | [8-K](/filings/0001524472-26-000123.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001524472-26-000123 |
| 2026-08-13 | 16:22 ET | [8-K](/filings/0001524472-26-000119.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001524472-26-000119 |
| 2026-07-28 | 11:53 ET | [10-Q](/filings/0001524472-26-000110.md) | Quarterly report, period 2026-06-30 | 0001524472-26-000110 |
| 2026-07-28 | 07:06 ET | [8-K](/filings/0001524472-26-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001524472-26-000108 |
| 2026-05-29 | 16:15 ET | [8-K](/filings/0001193125-26-248342.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-248342 |
| 2026-05-18 | 16:19 ET | [8-K](/filings/0001524472-26-000091.md) | 5.07 Shareholder vote results | 0001524472-26-000091 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001524472-26-000012.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/140ed5ec-20b0-4d3f-8f0b-f570ee6d4bb2)

## About the filer

- CIK: 1524472
- Tickers: XYL
- Exchange: NYSE
- SIC code: 3561 Pumps & Pumping Equipment
- State of incorporation: IN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:51 ET. No prices; not investment advice.